Health & Biotech
Doubling up: How ASX biotechs are multiplying their impact
Health Check: Opthea investors have $80m less to fight for after cash-burning quarter
ASX Health Quarterly Wrap: Dimerix inks fourth licensing deal, Audeara nails record revenue year
Biocurious: It’s a case of animal magnetism as Island eyes the FDA’s new rule on non-human testing
Unicorns Podcast: New low-dose supplement tackles knee pain as joint health market booms
EMVision gets ethics approval for two key studies, banks $400,000 milestone payment
Aroa posts third consecutive quarter of positive net cash flow
Health Check: A ‘manageable headwind’ as Trump slugs Europe with 15pc pharma tariff
Dopamine decoded: How to boost mood, sleep and more
Dr Boreham’s Crucible: Qbiotics hopes to crawl through IPO ‘window of opportunity’
Compumedics inks $24 million four-year distribution deals in China
Health Check: Clarity shares surge after ‘fast and sizeable’ $203m raise
Alterity reports positive results from open-label phase II trial of neurological disease drug
Tech-centric Bailador delivers standout FY25 with strong returns and strategic growth
Prescient focuses on advancing lead cancer drug toward pivotal trial
Neurizon closer to FDA clinical hold lift on ALS drug as it eyes crucial trial
Scott Power: ASX health stocks ‘catch a bid’, up 5.4pc over past five days
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
